Formulation: A solution in methyl acetate
Formal Name: (Z)-5-((2R,3S,4S)-4-hydroxy-2-((S,E)-3-hydroxyoct-1-en-1-yl-5,5,6,6,7,7,8,8,8-d9)-6-oxotetrahydro-2H-pyran-3-yl)pent-3-enoic acid
Purity: ≥99% deuterated forms (d1-d9)
Formula Markup: C18H19D9O6
Formula Weight: 349,5
Shelf life (days): 730
Notes: 11-dehydro-2,3-dinor Thromboxane B2-d9 (11-dehydro-2,3-dinor TXB2-d9) is intended for use as an internal standard for the quantification of 11-dehydro-2,3-dinor TXB2 (Item No. 19510) by GC- or LC-MS. 11-dehydro-2,3-dinor TXB2 is a metabolite of the TXA2 inactive metabolite TXB2 (Item No. 19030).{1249} It is formed from TXB2 by cytosolic aldehyde dehydrogenase (ALDH) and β-oxidation.{1249,20448} Levels of 11-dehydro-2,3-dinor TXB2 are increased 5.2-fold in a surgery-induced rat model of tendon overuse.{65670}